Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of stomach cancer in a Korean population

Anticancer Research

Volumn 25, Issue 3 B, 2005, Pages 2249-2252

  Kim, Jin Kyeoung ^a   Kim, Sehyun ^a   Han, Jin Hee ^a   Kim, Hyo Jin ^a   Chong, So Young ^a   Hong, Seong Pyo ^a   Hwang, Seong Gyu ^a   Ahn, Jung Yong ^a   Cha, Kwang Yul ^a   Oh, Doyeun ^a   Kim, Nam Keun ^a  

^a CHA University   (South Korea)

Author keywords

MTHFR; Polymorphism; Stomach cancer

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); GENOMIC DNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER RISK; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CEREBROVASCULAR DISEASE; CHINESE; COLON CANCER; CONTROLLED STUDY; DNA EXTRACTION; DNA METHYLATION; ESOPHAGUS CANCER; FEMALE; FOLATE METABOLISM; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; KOREA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STOMACH CANCER; WILD TYPE;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KOREA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; STOMACH NEOPLASMS;

EID: 21344460000     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Voorrips LE, Goldbohm RA, Brants HA, van Poppel GA, Sturmans F, Hermus RJ and van den Brandt PA: A prospective cohort study on antioxidant and folate intake and male lung cancer risk. Cancer Epidemiol Biomarkers Prev 9(4): 357-365, 2000.
2. Choi SW and Mason JB: Folate and carcinogenesis: an integrated scheme. J Nutr 130(2): 129-132, 2000.
3. Duthie SJ: Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull 55(3): 578-592, 1999.
4. Bandera EV, Freudenheim JL, Marshall JR, Zielezny M, Priore RL, Brasure J, Baptiste M and Graham S: Diet and alcohol consumption and lung cancer risk in the New York State Cohort (United States). Cancer Causes Control 8(6): 828-840, 1997.
5. Wagner C: Biochemical role of folate in cellular metabolism. In: Bailey LB (ed.), Folate in Health and Disease, pp. 23-42, New York: Marcel Dekker, 1995.
6. Kim YI: Methylenetetrahydrofolate reductase polymorphisms, folate, and cancer risk: a paradigm of gene-nutrient interactions in carcinogenesis. Nutr Rev 58(7): 205-209, 2000.
7. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP and Rozen R: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10(1): 111-113, 1995.
8. Weisberg I, Tran P, Christensen B, Sibani S and Rozen R: A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64(3): 169-172, 1998.
9. Chen J, Giovannucci EL and Hunter DJ: MTHFR polymorphism, methyl-replete diets and the risk of colorectal carcinoma and adenoma among U.S. men and women: an example of gene-environment interactions in colorectal tumorigenesis. J Nutr 129(25 Suppl): 560S-564S, 1999.
10. van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP and Blom HJ: A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62(5): 1044-1051, 1998.
11. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, Willett WC, Selhub J, Hennekens CH and Rozen R: Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 57(6): 1098-1102, 1997.
12. Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA and Morgan G: Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 96(22): 12810-12815, 1999.
13. Shen H, Spitz MR, Wang LE, Hong WK and Wei Q: Polymorphisms of methylenetetrahydrofolate reductase and risk of lung cancer: a case-control study. Cancer Epidemiol Biomarkers Prev 10(4): 397-401, 2001.
14. Song C, Xing D, Tan W, Wei Q and Lin D: Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 61(8): 3272-3275, 2001.
15. Miao X, Xing D, Tan W, Qi J, Lu W and Lin D: Susceptibility to gastric cardia adenocarcinoma and genetic polymorphisms in methylenetetrahydrofolate reductase in an at-risk Chinese population. Cancer Epidemiol Biomarkers Prev 11(11): 1454-1458, 2002.
16. Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, Ratnasinghe DL, Dawsey SM, Dong ZW, Taylor PR and Mark SD: Esophageal and gastric cardia risk and folate- and vitamin B12-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev 12: 1222-1226, 2003.
17. Shen H, Xu Y, Zheng Y, Qian Y, Yu R, Qin Y, Wang X, Spitz MR and Wei Q: Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer 95(5): 332-336, 2001.
18. Choi BO, Kim NK, Kim SH, Kang MS, Lee S, Ahn JY, Kim OJ, Kim S and Oh D: Homozygous C677T mutation in the MTHFR gene as an independent risk factor for multiple small-artery occlusions. Thromb Res 111(1-2): 39-44, 2003.
19. Sadewa AH, Sunarti, Sutomo R, Hayashi C, Lee MJ, Ayaki H, Sofro AS, Matsuo M and Nishio H: The C677T mutation in the methylenetetrahydrofolate reductase gene among the Indonesian Javanese population. Kobe J Med Sci 48(5-6): 137-144, 2002.
20. Kim NK, Kang GD, Kim HJ, Kim SH, Nam YS, Lee S, Chung HM, Kang SH, Ahn JY, Choi BO, Hwang SG and Oh D: Genetic polymorphisms of 5,10- methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) in healthy Korean. Korean J Genetics 24(2): 227-234, 2002.
21. Cohen V, Panet-Raymond V, Sabbaghian N, Morin I, Batist G and Rozen R: Methylenetetrahydrofolate reductase polymorphism in advanced colorectal cancer: a novel genomic predictor of clinical response to fluoropyrimidine-based chemotherapy. Clin Cancer Res 9(5): 1611-1615, 2003.
22. Sohn KJ, Croxford R, Yates Z, Lucock M and Kim YI: Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate. J Natl Cancer Inst 96(2): 134-144, 2004.
23. Wisotzkey JD, Toman J, Bell T, Monk JS and Jones D: MTHFR (C677T) polymorphisms and stage III colon cancer. Mol Diagn 4(2): 95-99, 1999.
24. Kawakami K, Ruszkiewicz A, Bennett G, Moore J, Watanabe G and Iacopetta B: The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductase. Clin Cancer Res 9(16): 5860-5865, 2003.
25. Langsenlehner U, Krippl P, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Weitzer W and Samonigg H: The common 677C>T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer risk. Breast Cancer Res Treat 81(2): 169-172, 2003.
26. Etienne MC, IIc K, Formento JL, Laurent-Puig P, Formento P, Cheradame S, Fischel JL and Milano G: Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity. Br J Cancer 90(2): 526-534, 2004.